Tuesday, December 08, 2020
In recent years, global pharmaceutical supply chains have increased in complexity and scrutinization, due to the involvement of many players with new guidance, regulation and compendial requirements. For example, compliance with the European Good ...
Sunday, September 24, 2017
With the publication of the European GDP guideline, to better protect the pharmaceutical supply chain all actors in the pharmaceutical supply chain are obliged to perform a full review of all associated Quality Systems.
Wednesday, September 30, 2015
The world is a far less certain place today than it was just a decade ago.
In this changing environment pharmaceutical companies have moved
from being regional to global entities, which have significantly increased
risks within our industry.